The Behavioral Profile of the Potent and Selective mGlu5 Receptor Antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in Rodent Models of Anxiety

This publication has 36 references indexed in Scilit:

• 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]- pyridine: A Potent and Highly Selective Metabotropic Glutamate Subtype 5 Receptor Antagonist with Anxiolytic Activity
  Journal of Medicinal Chemistry, 2002
• Anxiolytic-like activity of the mGluR5 antagonist MPEP: A comparison with diazepam and buspirone
  Pharmacology Biochemistry and Behavior, 2002
• [3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine Binding to Metabotropic Glutamate Receptor Subtype 5 in Rodent Brain: In Vitro and in Vivo Characterization
  The Journal of Pharmacology and Experimental Therapeutics, 2002
• The psychobiology of anxiolytic drugs: Part 2: pharmacological treatments of anxiety
  Pharmacology & Therapeutics, 2000
• PHARMACOLOGY AND FUNCTIONS OF METABOTROPIC GLUTAMATE RECEPTORS
  Annual Review of Pharmacology and Toxicology, 1997
• Anticonflict Effect of Alpidem as Compared with the Benzodiazepine Alprazolam in Rats
  Pharmacology Biochemistry and Behavior, 1997
• Economic costs of anxiety disorders
  Anxiety, 1996
• Heterologous expression of metabotropic glutamate receptors in adult rat sympathetic neurons: Subtype-specific coupling to ion channels
  Neuron, 1995
• Fear-potentiated startle: A neural and pharmacological analysis
  Behavioural Brain Research, 1993
• The metabotropic glutamate receptor (mGluRlα) is concentrated at perisynaptic membrane of neuronal subpopulations as detected by immunogold reaction
  Neuron, 1993